cagrilintide cas number 10mg | 99%+ Verified Purity laboratory-only Syringe Size:31G BPC-157 10mg | 10-Vial

cagrilintide cas number 10mg | 99%+ Verified Purity laboratory-only Syringe Size:31G BPC-157 10mg | 10-Vial

BPC-157 10mg | 10-Vial Kit | 100mg Total | QSC

• HCPCS J-code for medication

laboratory-only

Syringe Size:31G

the 本发明的有益效果是：本发明的BPC157肽固相合成制备方法具有以下特点：原辅材料来源方便，工艺稳定，收率高，质量可控，产品纯度高，生产周期短，成本低，可规模化生产。采用本发明方法制备的BPC157肽极具市场竞争力，其生产规模完全能够满足BPC157肽的应用需求，其质量完全能够达到BPC157肽的应用要求。 The beneficial effects of the present invention are: the preparation method of BPC157 peptide solid-phase synthesis of the present invention has the following characteristics: the source of raw and auxiliary materials is convenient, the process is stable, the yield is high, the quality is controllable, the product purity is high, the production cycle is short, the cost is low, and it can Large-scale production